Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020
Scientific literature:
Epi surveillance
COVID-19
Dataset Records for COVID-19
Displaying 901 - 950 of 1636
Nepal Coronavirus Disease Prevention Map: Movement Between Administrative Regions - Facebook Data for Good 2020-2022
Geospatial data:
GPS coordinates (GIS)
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys
GHDx Entry last modified on: Mar 14, 2022
Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors
GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Preprint
GHDx Entry last modified on: May 12, 2022
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
GHDx Entry last modified on: Jan 31, 2024
Psychophysical evaluation of chemosensory functions 5weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients
GHDx Entry last modified on: Mar 14, 2022
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
GHDx Entry last modified on: Feb 1, 2024
Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State
GHDx Entry last modified on: Jan 31, 2024
Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry
GHDx Entry last modified on: Mar 14, 2022
Universal severe acute respiratory syndrome coronavirus 2 testing of pregnant women admitted for delivery in 2 Italian regions
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogota, Colombia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020
GHDx Entry last modified on: Jan 31, 2024
Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned
GHDx Entry last modified on: May 12, 2022
Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study
GHDx Entry last modified on: Jan 31, 2024
COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic
GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 population-based prevalence, risk factors, hospitalization, and fatality rates in southern Brazil
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence Study in Pimpri-Chinchwad, Maharashtra, India Coinciding with Falling Trend - Do the Results Suggest Imminent Herd Immunity? Preprint
GHDx Entry last modified on: Mar 14, 2022
Clinical course of coronavirus disease-2019 in pregnancy
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020
GHDx Entry last modified on: May 12, 2022
Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 of IgG antibody by ELISA: Community-based, cross-sectional study from urban area of Malegaon, Maharashtra
GHDx Entry last modified on: Jan 31, 2024
Ninety days post-hospitalization evaluation of residual COVID-19 symptoms through a phone call check list
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020<sup>1</sup>
GHDx Entry last modified on: May 12, 2022
High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes
GHDx Entry last modified on: Mar 14, 2022
Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021
GHDx Entry last modified on: Apr 1, 2025
Coronavirus Disease 2019 (COVID-19) Seropositivity and Asymptomatic Rates in Healthcare Workers Are Associated with Job Function and Masking
GHDx Entry last modified on: Jan 31, 2024
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic
GHDx Entry last modified on: Jan 31, 2024
Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal
GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
GHDx Entry last modified on: Apr 8, 2022
SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey
GHDx Entry last modified on: Mar 14, 2022
COVID-19 Pandemic Preparedness - Infection Rate and Infection Fatality Ratio Estimates 2020-2021
GHDx Entry last modified on: Jul 28, 2023
Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19)
GHDx Entry last modified on: Apr 10, 2023
Analysis of prevalence and sociodemographic conditions among women in labor with and without COVID-19 in public hospitals in Chile
GHDx Entry last modified on: Apr 10, 2023
SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021
GHDx Entry last modified on: Apr 10, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns
GHDx Entry last modified on: Apr 10, 2023
Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People
GHDx Entry last modified on: Apr 10, 2023
COVID-19 vaccine equity and booster doses
GHDx Entry last modified on: Dec 12, 2023
Symptoms persisting after hospitalisation for COVID-19: 12 months interim results of the CO-FLOW study
GHDx Entry last modified on: Mar 22, 2024
Prevalence and Persistence of Symptoms in Adult COVID-19 Survivors 3 and 18 Months after Discharge from Hospital or Corona Hotels
GHDx Entry last modified on: Mar 22, 2024
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement
GHDx Entry last modified on: Mar 22, 2024
Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study
GHDx Entry last modified on: Mar 22, 2024
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
GHDx Entry last modified on: Mar 22, 2024
Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19
GHDx Entry last modified on: Oct 23, 2024
2019 Novel Coronavirus COVID-19 (2019-nCoV) Data Repository by Johns Hopkins CSSE 2020-2022
GHDx Entry last modified on: Jan 22, 2024
United States COVID Tracking Project API - Historic State Data 2020-2021
GHDx Entry last modified on: Aug 29, 2023
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors
GHDx Entry last modified on: Mar 14, 2022
Subscribe